FDA Drug Application (040327) for ORPHENADRINE CITRATE by SANDOZ

Back to FDA Applications sponsored by SANDOZ

Application Number040327
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage100MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameORPHENADRINE CITRATE
Active IngredientORPHENADRINE CITRATE

Active IngredientCount
List of drugs with Active Ingredient ORPHENADRINE CITRATE9


Back to FDA Applications sponsored by SANDOZ